Basmisanil
CAS: 1159600-41-5
Ref. 3D-FD158569
| 10mg | Discontinued | ||
| 25mg | Discontinued | ||
| 50mg | Discontinued | ||
| 100mg | Discontinued | ||
| 250mg | Discontinued |
Product Information
Name:
Basmisanil
Synonyms:
- 1,1-Dioxo-4-thiomorpholinyl)[6-[[3-(4-fluorophenyl)-5-methylisoxazol-4-yl]methoxy]pyridin-3-yl]methanone
Description:
Basmisanil is an experimental drug that has shown efficacy in treating psychotic disorders. It is a GABA-A antagonist, which blocks the binding of gamma-aminobutyric acid (GABA) to its receptors. Basmisanil has been shown to inhibit protein synthesis in vitro and also prevents the growth factor from binding with its receptor, thereby blocking the neurotrophic effects. Basmisanil has been shown to be chemically stable and is not toxic to cells, making it a good candidate for use as a diagnostic agent and/or treatment of autoimmune diseases.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:
Chemical properties
Molecular weight:
445.47 g/mol
Formula:
C21H20FN3O5S
Purity:
Min. 95%
InChI:
InChI=1S/C21H20FN3O5S/c1-14-18(20(24-30-14)15-2-5-17(22)6-3-15)13-29-19-7-4-16(12-23-19)21(26)25-8-10-31(27,28)11-9-25/h2-7,12H,8-11,13H2,1H3
InChI key:
InChIKey=VCGRFBXVSFAGGA-UHFFFAOYSA-N
SMILES:
Cc1onc(-c2ccc(F)cc2)c1COc1ccc(C(=O)N2CCS(=O)(=O)CC2)cn1
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
